Rank | Gene Set | Z-score |
---|---|---|
1 | signal peptide processing (GO:0006465) | 7.58624272 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.70976279 |
3 | negative regulation of cell killing (GO:0031342) | 6.70976279 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.67883619 |
5 | sequestering of metal ion (GO:0051238) | 6.26693807 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.26529266 |
7 | modulation by symbiont of host defense response (GO:0052031) | 6.26529266 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.26529266 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.26529266 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.26529266 |
11 | modulation by symbiont of host immune response (GO:0052553) | 6.26529266 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.55498376 |
13 | central nervous system myelination (GO:0022010) | 5.29934770 |
14 | axon ensheathment in central nervous system (GO:0032291) | 5.29934770 |
15 | detection of other organism (GO:0098543) | 5.24766883 |
16 | macrophage activation involved in immune response (GO:0002281) | 5.17435711 |
17 | protein maturation by protein folding (GO:0022417) | 5.07840705 |
18 | endocrine pancreas development (GO:0031018) | 5.02959575 |
19 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.99367717 |
20 | detection of bacterium (GO:0016045) | 4.96149271 |
21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.94724771 |
22 | detection of molecule of bacterial origin (GO:0032490) | 4.87525069 |
23 | detection of external biotic stimulus (GO:0098581) | 4.67365425 |
24 | response to interleukin-15 (GO:0070672) | 4.67239941 |
25 | negative regulation of interleukin-12 production (GO:0032695) | 4.66469799 |
26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.66188398 |
27 | response to peptidoglycan (GO:0032494) | 4.65351875 |
28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.59274243 |
29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.52892921 |
30 | COPI coating of Golgi vesicle (GO:0048205) | 4.51343760 |
31 | Golgi transport vesicle coating (GO:0048200) | 4.51343760 |
32 | neutrophil activation (GO:0042119) | 4.49372501 |
33 | cellular extravasation (GO:0045123) | 4.48217943 |
34 | nucleotide transmembrane transport (GO:1901679) | 4.45779558 |
35 | cellular response to interleukin-15 (GO:0071350) | 4.39665631 |
36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.35143544 |
37 | cellular response to type I interferon (GO:0071357) | 4.32067866 |
38 | type I interferon signaling pathway (GO:0060337) | 4.32067866 |
39 | response to type I interferon (GO:0034340) | 4.30357400 |
40 | response to host immune response (GO:0052572) | 4.29131697 |
41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.29131697 |
42 | microglial cell activation (GO:0001774) | 4.24679267 |
43 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.13951851 |
44 | immunoglobulin mediated immune response (GO:0016064) | 4.12769506 |
45 | detection of biotic stimulus (GO:0009595) | 4.12404579 |
46 | peptide hormone processing (GO:0016486) | 4.10106580 |
47 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.06072070 |
48 | regulation of gamma-delta T cell activation (GO:0046643) | 4.05450616 |
49 | granulocyte activation (GO:0036230) | 3.99863016 |
50 | ER overload response (GO:0006983) | 3.93060964 |
51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.92956670 |
52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.86848834 |
53 | response to host (GO:0075136) | 3.86848834 |
54 | response to host defenses (GO:0052200) | 3.86848834 |
55 | macrophage activation (GO:0042116) | 3.83543297 |
56 | cellular response to zinc ion (GO:0071294) | 3.74925651 |
57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74720040 |
58 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.72958006 |
59 | myeloid cell activation involved in immune response (GO:0002275) | 3.70546809 |
60 | positive regulation of cell fate commitment (GO:0010455) | 3.62811263 |
61 | response to dietary excess (GO:0002021) | 3.59116295 |
62 | GPI anchor biosynthetic process (GO:0006506) | 3.59100395 |
63 | response to interferon-alpha (GO:0035455) | 3.56886030 |
64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.52776759 |
65 | myeloid leukocyte mediated immunity (GO:0002444) | 3.52657476 |
66 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.52305114 |
67 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.52305114 |
68 | regulation of mast cell degranulation (GO:0043304) | 3.50979057 |
69 | neutrophil activation involved in immune response (GO:0002283) | 3.49723019 |
70 | germinal center formation (GO:0002467) | 3.45603175 |
71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45543833 |
72 | glandular epithelial cell differentiation (GO:0002067) | 3.44761183 |
73 | COPII vesicle coating (GO:0048208) | 3.44696184 |
74 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.44625443 |
75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.44561656 |
76 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.44261056 |
77 | fatty acid elongation (GO:0030497) | 3.43552130 |
78 | defense response to protozoan (GO:0042832) | 3.42603477 |
79 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.39322024 |
80 | positive regulation of mast cell activation (GO:0033005) | 3.37173613 |
81 | positive regulation of interferon-alpha production (GO:0032727) | 3.36894384 |
82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36665634 |
83 | regulation of mast cell activation (GO:0033003) | 3.35353120 |
84 | dendritic cell migration (GO:0036336) | 3.31882513 |
85 | dendritic cell chemotaxis (GO:0002407) | 3.29135286 |
86 | fucosylation (GO:0036065) | 3.28208508 |
87 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28066900 |
88 | B cell mediated immunity (GO:0019724) | 3.27860297 |
89 | GPI anchor metabolic process (GO:0006505) | 3.26968879 |
90 | activated T cell proliferation (GO:0050798) | 3.25178016 |
91 | B cell receptor signaling pathway (GO:0050853) | 3.24636428 |
92 | negative regulation of JUN kinase activity (GO:0043508) | 3.23191707 |
93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.23005070 |
94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.22953924 |
95 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.22498370 |
96 | fucose metabolic process (GO:0006004) | 3.22097537 |
97 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.21442360 |
98 | regulation of T cell tolerance induction (GO:0002664) | 3.20934724 |
99 | regulation of interferon-alpha production (GO:0032647) | 3.18869953 |
100 | positive regulation of insulin secretion (GO:0032024) | 3.18156899 |
101 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.16435142 |
102 | mannosylation (GO:0097502) | 3.11767509 |
103 | regulation of tolerance induction (GO:0002643) | 3.11572646 |
104 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.11349835 |
105 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.10363777 |
106 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.10363777 |
107 | negative regulation of innate immune response (GO:0045824) | 3.09865947 |
108 | respiratory burst (GO:0045730) | 3.09475616 |
109 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.09182364 |
110 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.09053337 |
111 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.09008059 |
112 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.08248609 |
113 | regulation of regulatory T cell differentiation (GO:0045589) | 3.07544011 |
114 | regulation of B cell differentiation (GO:0045577) | 3.05577566 |
115 | leukocyte aggregation (GO:0070486) | 3.04301685 |
116 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.02903367 |
117 | negative regulation of type 2 immune response (GO:0002829) | 3.02041593 |
118 | negative regulation of interleukin-6 production (GO:0032715) | 3.00323827 |
119 | * leukocyte migration involved in inflammatory response (GO:0002523) | 3.00314404 |
120 | tolerance induction (GO:0002507) | 3.00276370 |
121 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.99510371 |
122 | neutrophil chemotaxis (GO:0030593) | 2.97631268 |
123 | response to protozoan (GO:0001562) | 2.97554777 |
124 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.97364945 |
125 | interferon-gamma secretion (GO:0072643) | 2.96910168 |
126 | intracellular pH reduction (GO:0051452) | 2.93625365 |
127 | magnesium ion transport (GO:0015693) | 2.92635595 |
128 | negative regulation of phagocytosis (GO:0050765) | 2.89187782 |
129 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.88247460 |
130 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.87731051 |
131 | positive regulation of defense response to virus by host (GO:0002230) | 2.84025059 |
132 | telomere maintenance via telomerase (GO:0007004) | 2.83185196 |
133 | regulation of lipoprotein metabolic process (GO:0050746) | 2.83179957 |
134 | negative regulation of interleukin-10 production (GO:0032693) | 2.81177996 |
135 | C-terminal protein lipidation (GO:0006501) | 2.79242060 |
136 | response to lipoprotein particle (GO:0055094) | 2.79240567 |
137 | defense response to fungus (GO:0050832) | 2.78312653 |
138 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.77982220 |
139 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77982220 |
140 | negative regulation of bone resorption (GO:0045779) | 2.77849131 |
141 | cotranslational protein targeting to membrane (GO:0006613) | 2.77514402 |
142 | GDP-mannose metabolic process (GO:0019673) | 2.76686476 |
143 | nucleoside diphosphate catabolic process (GO:0009134) | 2.76339140 |
144 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.74820574 |
145 | neutrophil mediated immunity (GO:0002446) | 2.74086062 |
146 | protein targeting to ER (GO:0045047) | 2.74048140 |
147 | response to redox state (GO:0051775) | 2.73022350 |
148 | glycosylceramide metabolic process (GO:0006677) | 2.72942408 |
149 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.72888686 |
150 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.72512893 |
151 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.72212971 |
152 | auditory receptor cell differentiation (GO:0042491) | 2.71844527 |
153 | oligodendrocyte differentiation (GO:0048709) | 2.71475067 |
154 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.71325626 |
155 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.71325626 |
156 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70326652 |
157 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.69958029 |
158 | leukocyte degranulation (GO:0043299) | 2.69117072 |
159 | photoreceptor cell differentiation (GO:0046530) | 2.68908625 |
160 | eye photoreceptor cell differentiation (GO:0001754) | 2.68908625 |
161 | pH reduction (GO:0045851) | 2.68521926 |
162 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.68483924 |
163 | regulation of growth of symbiont in host (GO:0044126) | 2.68483924 |
164 | negative regulation of growth of symbiont in host (GO:0044130) | 2.68483924 |
165 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.68483924 |
166 | nucleotide transport (GO:0006862) | 2.65841235 |
167 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.65485706 |
168 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.64070493 |
169 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.63352664 |
170 | protein localization to endoplasmic reticulum (GO:0070972) | 2.62379070 |
171 | negative regulation of myotube differentiation (GO:0010832) | 2.61393356 |
172 | adaptation of signaling pathway (GO:0023058) | 2.60756709 |
173 | axon ensheathment (GO:0008366) | 2.58195382 |
174 | ensheathment of neurons (GO:0007272) | 2.58195382 |
175 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.57418514 |
176 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.57418514 |
177 | myelination (GO:0042552) | 2.56363974 |
178 | positive regulation of steroid hormone secretion (GO:2000833) | 2.55352297 |
179 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.53504589 |
180 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.51843474 |
181 | regulation of vacuole organization (GO:0044088) | 2.51361305 |
182 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.48583250 |
183 | positive regulation of peptide hormone secretion (GO:0090277) | 2.48195909 |
184 | regulation of autophagic vacuole assembly (GO:2000785) | 2.46929546 |
185 | viral protein processing (GO:0019082) | 2.44583266 |
186 | replicative senescence (GO:0090399) | 2.43368834 |
187 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.42407363 |
188 | regulation of insulin secretion (GO:0050796) | 2.41861131 |
189 | amyloid precursor protein catabolic process (GO:0042987) | 2.41741718 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.31172209 |
2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.05835643 |
3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.78846948 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.20217206 |
5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.09552804 |
6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.07726726 |
7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.05847663 |
8 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.90174275 |
9 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.80666236 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68987983 |
11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.51043303 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.48111793 |
13 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.48000964 |
14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.46306202 |
15 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45608795 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.44910952 |
17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.42847803 |
18 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39973064 |
19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.25827652 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24065436 |
21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.21867695 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17861317 |
23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17142178 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.16086183 |
25 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.14847850 |
26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.11197244 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03619765 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99499619 |
29 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.93969797 |
30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93090557 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87604754 |
32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83969663 |
33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78288790 |
34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76961350 |
35 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71084895 |
36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70566161 |
37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70096640 |
38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69458083 |
39 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67478368 |
40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64794386 |
41 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.63106742 |
42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62186892 |
43 | MAF_26560356_Chip-Seq_TH2_Human | 1.59852870 |
44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.59802900 |
45 | MYB_26560356_Chip-Seq_TH2_Human | 1.58039565 |
46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51203296 |
47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50643186 |
48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46269846 |
49 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.45782830 |
50 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43859403 |
51 | MYC_22102868_ChIP-Seq_BL_Human | 1.41951223 |
52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40162103 |
53 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39977926 |
54 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38622395 |
55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36512872 |
56 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.35267158 |
57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34061769 |
58 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34056137 |
59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33546583 |
60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33377507 |
61 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.32963318 |
62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32752504 |
63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32284098 |
64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32116293 |
65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30428579 |
66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30354420 |
67 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.30208328 |
68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29381563 |
69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29137439 |
70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28798155 |
71 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28074849 |
72 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25152652 |
73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22664509 |
74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21598261 |
75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20378578 |
76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20128967 |
77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19517912 |
78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19087802 |
79 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17705109 |
80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17418530 |
81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17243972 |
82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16254579 |
83 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.16108108 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15527200 |
85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14317390 |
86 | MYB_26560356_Chip-Seq_TH1_Human | 1.13319660 |
87 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10470665 |
88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09665913 |
89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09583433 |
90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09280480 |
91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07936493 |
92 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07916178 |
93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07282202 |
94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07239217 |
95 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.07122102 |
96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06840849 |
97 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.05659827 |
98 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.03567422 |
99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03047711 |
100 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02905700 |
101 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02324285 |
102 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01659811 |
103 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01580267 |
104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01369663 |
105 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01317072 |
106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01261376 |
107 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.98301613 |
108 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97980512 |
109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97296143 |
110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97223269 |
111 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97089076 |
112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96970296 |
113 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96440137 |
114 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96439127 |
115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95875298 |
116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94563897 |
117 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94076368 |
118 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93409700 |
119 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.93097386 |
120 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.92909463 |
121 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.92589305 |
122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90886733 |
123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89496763 |
124 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89075563 |
125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88743990 |
126 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.88558890 |
127 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.87975190 |
128 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87812307 |
129 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.87719755 |
130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.87626534 |
131 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86165663 |
132 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.85378888 |
133 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.84993799 |
134 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84515921 |
135 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84132881 |
136 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81066978 |
137 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.78319340 |
138 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78288631 |
139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76533206 |
140 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74684551 |
141 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.74465911 |
142 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73971833 |
143 | P300_27268052_Chip-Seq_Bcells_Human | 0.72067957 |
144 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.69512268 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000013_abnormal_adipose_tissue | 3.78838274 |
2 | MP0003183_abnormal_peptide_metabolism | 3.47397625 |
3 | MP0002877_abnormal_melanocyte_morpholog | 3.43205972 |
4 | MP0004043_abnormal_pH_regulation | 3.06545481 |
5 | MP0005379_endocrine/exocrine_gland_phen | 3.03625600 |
6 | MP0002693_abnormal_pancreas_physiology | 2.88306908 |
7 | MP0006082_CNS_inflammation | 2.70069822 |
8 | MP0000920_abnormal_myelination | 2.66298038 |
9 | MP0000003_abnormal_adipose_tissue | 2.49722780 |
10 | MP0001944_abnormal_pancreas_morphology | 2.46069488 |
11 | MP0001986_abnormal_taste_sensitivity | 2.37460066 |
12 | MP0002277_abnormal_respiratory_mucosa | 2.31969386 |
13 | MP0005645_abnormal_hypothalamus_physiol | 2.25312993 |
14 | * MP0001533_abnormal_skeleton_physiology | 2.14959454 |
15 | MP0005670_abnormal_white_adipose | 2.14760197 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.08042582 |
17 | MP0005387_immune_system_phenotype | 2.04994194 |
18 | MP0001790_abnormal_immune_system | 2.04994194 |
19 | * MP0005000_abnormal_immune_tolerance | 2.01589466 |
20 | MP0003195_calcinosis | 2.00949603 |
21 | MP0008057_abnormal_DNA_replication | 1.98729403 |
22 | MP0005375_adipose_tissue_phenotype | 1.97879738 |
23 | MP0002132_abnormal_respiratory_system | 1.97396491 |
24 | MP0006072_abnormal_retinal_apoptosis | 1.95236440 |
25 | MP0002837_dystrophic_cardiac_calcinosis | 1.93037709 |
26 | MP0005220_abnormal_exocrine_pancreas | 1.91964106 |
27 | MP0002398_abnormal_bone_marrow | 1.88291940 |
28 | MP0003303_peritoneal_inflammation | 1.84799700 |
29 | MP0009764_decreased_sensitivity_to | 1.83535923 |
30 | MP0003763_abnormal_thymus_physiology | 1.83437550 |
31 | MP0002638_abnormal_pupillary_reflex | 1.83402011 |
32 | MP0001835_abnormal_antigen_presentation | 1.83370152 |
33 | MP0009785_altered_susceptibility_to | 1.80681879 |
34 | MP0005671_abnormal_response_to | 1.75795692 |
35 | MP0005058_abnormal_lysosome_morphology | 1.74008553 |
36 | MP0004185_abnormal_adipocyte_glucose | 1.71837227 |
37 | * MP0010155_abnormal_intestine_physiology | 1.71132013 |
38 | MP0002148_abnormal_hypersensitivity_rea | 1.68335660 |
39 | * MP0002419_abnormal_innate_immunity | 1.64906625 |
40 | MP0003283_abnormal_digestive_organ | 1.63359374 |
41 | MP0003300_gastrointestinal_ulcer | 1.63239516 |
42 | MP0009278_abnormal_bone_marrow | 1.62833036 |
43 | MP0010386_abnormal_urinary_bladder | 1.60274244 |
44 | MP0000689_abnormal_spleen_morphology | 1.57729797 |
45 | MP0003436_decreased_susceptibility_to | 1.54665023 |
46 | * MP0003724_increased_susceptibility_to | 1.54548637 |
47 | MP0002078_abnormal_glucose_homeostasis | 1.54431990 |
48 | MP0001661_extended_life_span | 1.54374926 |
49 | MP0002722_abnormal_immune_system | 1.53977419 |
50 | MP0004947_skin_inflammation | 1.53602346 |
51 | * MP0005025_abnormal_response_to | 1.52588496 |
52 | MP0002909_abnormal_adrenal_gland | 1.52553408 |
53 | MP0005666_abnormal_adipose_tissue | 1.50654229 |
54 | MP0005409_darkened_coat_color | 1.49880443 |
55 | MP0003828_pulmonary_edema | 1.48270466 |
56 | * MP0002429_abnormal_blood_cell | 1.44798232 |
57 | MP0000462_abnormal_digestive_system | 1.42349091 |
58 | MP0004883_abnormal_blood_vessel | 1.41216591 |
59 | * MP0002723_abnormal_immune_serum | 1.40242722 |
60 | MP0005075_abnormal_melanosome_morpholog | 1.39438135 |
61 | MP0009333_abnormal_splenocyte_physiolog | 1.37484466 |
62 | MP0002938_white_spotting | 1.35719670 |
63 | MP0000703_abnormal_thymus_morphology | 1.35413423 |
64 | * MP0002420_abnormal_adaptive_immunity | 1.30534431 |
65 | MP0000685_abnormal_immune_system | 1.29833837 |
66 | MP0003690_abnormal_glial_cell | 1.28541698 |
67 | MP0003136_yellow_coat_color | 1.27777996 |
68 | MP0000678_abnormal_parathyroid_gland | 1.27307518 |
69 | * MP0001819_abnormal_immune_cell | 1.27063064 |
70 | MP0003172_abnormal_lysosome_physiology | 1.25411511 |
71 | MP0004510_myositis | 1.24330903 |
72 | MP0008260_abnormal_autophagy | 1.23839655 |
73 | MP0001800_abnormal_humoral_immune | 1.21424962 |
74 | MP0003075_altered_response_to | 1.20639049 |
75 | MP0005310_abnormal_salivary_gland | 1.20402913 |
76 | MP0005174_abnormal_tail_pigmentation | 1.19292927 |
77 | MP0005451_abnormal_body_composition | 1.17947368 |
78 | MP0004381_abnormal_hair_follicle | 1.15083210 |
79 | MP0005408_hypopigmentation | 1.14878382 |
80 | MP0005164_abnormal_response_to | 1.14754679 |
81 | MP0002452_abnormal_antigen_presenting | 1.13373152 |
82 | * MP0003866_abnormal_defecation | 1.12156420 |
83 | MP0003950_abnormal_plasma_membrane | 1.12003439 |
84 | MP0003959_abnormal_lean_body | 1.11652946 |
85 | MP0000858_altered_metastatic_potential | 1.10860551 |
86 | MP0002876_abnormal_thyroid_physiology | 1.10751449 |
87 | MP0005397_hematopoietic_system_phenotyp | 1.09506486 |
88 | MP0001545_abnormal_hematopoietic_system | 1.09506486 |
89 | MP0001502_abnormal_circadian_rhythm | 1.08027989 |
90 | MP0005084_abnormal_gallbladder_morpholo | 1.05770932 |
91 | MP0002971_abnormal_brown_adipose | 1.04210434 |
92 | MP0001348_abnormal_lacrimal_gland | 1.03665208 |
93 | MP0003186_abnormal_redox_activity | 1.03571438 |
94 | MP0002138_abnormal_hepatobiliary_system | 1.01633600 |
95 | MP0002933_joint_inflammation | 1.00851937 |
96 | MP0001851_eye_inflammation | 1.00323652 |
97 | MP0000569_abnormal_digit_pigmentation | 0.99200761 |
98 | MP0002998_abnormal_bone_remodeling | 0.99027739 |
99 | * MP0001845_abnormal_inflammatory_respons | 0.98974172 |
100 | MP0000613_abnormal_salivary_gland | 0.97609331 |
101 | MP0005464_abnormal_platelet_physiology | 0.97122680 |
102 | MP0005452_abnormal_adipose_tissue | 0.96254303 |
103 | MP0003634_abnormal_glial_cell | 0.94828386 |
104 | * MP0000716_abnormal_immune_system | 0.94127528 |
105 | MP0005166_decreased_susceptibility_to | 0.92489631 |
106 | * MP0002405_respiratory_system_inflammati | 0.92464830 |
107 | MP0001663_abnormal_digestive_system | 0.91917105 |
108 | MP0005535_abnormal_body_temperature | 0.91635820 |
109 | MP0004742_abnormal_vestibular_system | 0.91332811 |
110 | MP0003045_fibrosis | 0.90768063 |
111 | MP0000015_abnormal_ear_pigmentation | 0.90745740 |
112 | MP0001765_abnormal_ion_homeostasis | 0.90529783 |
113 | MP0002166_altered_tumor_susceptibility | 0.90410270 |
114 | MP0005448_abnormal_energy_balance | 0.90121060 |
115 | MP0009643_abnormal_urine_homeostasis | 0.90026365 |
116 | MP0002396_abnormal_hematopoietic_system | 0.89413771 |
117 | MP0009780_abnormal_chondrocyte_physiolo | 0.88911036 |
118 | MP0005171_absent_coat_pigmentation | 0.87903324 |
119 | * MP0000465_gastrointestinal_hemorrhage | 0.87365277 |
120 | MP0004264_abnormal_extraembryonic_tissu | 0.86909911 |
121 | MP0006036_abnormal_mitochondrial_physio | 0.85311681 |
122 | MP0001485_abnormal_pinna_reflex | 0.85248203 |
123 | MP0000343_altered_response_to | 0.85221709 |
124 | * MP0008469_abnormal_protein_level | 0.82653037 |
125 | MP0001873_stomach_inflammation | 0.82465902 |
126 | MP0001905_abnormal_dopamine_level | 0.81999119 |
127 | * MP0005390_skeleton_phenotype | 0.81478213 |
128 | MP0003953_abnormal_hormone_level | 0.80916539 |
129 | MP0003806_abnormal_nucleotide_metabolis | 0.80654359 |
130 | MP0002653_abnormal_ependyma_morphology | 0.80653141 |
131 | * MP0002118_abnormal_lipid_homeostasis | 0.80568503 |
132 | MP0002928_abnormal_bile_duct | 0.80233271 |
133 | MP0000490_abnormal_crypts_of | 0.79990727 |
134 | MP0005253_abnormal_eye_physiology | 0.79388143 |
135 | MP0002095_abnormal_skin_pigmentation | 0.79130414 |
136 | * MP0009763_increased_sensitivity_to | 0.78819783 |
137 | MP0002970_abnormal_white_adipose | 0.77972529 |
138 | MP0008004_abnormal_stomach_pH | 0.77742162 |
139 | MP0005334_abnormal_fat_pad | 0.77268831 |
140 | MP0005377_hearing/vestibular/ear_phenot | 0.74863607 |
141 | MP0003878_abnormal_ear_physiology | 0.74863607 |
142 | MP0003448_altered_tumor_morphology | 0.73369677 |
143 | MP0003787_abnormal_imprinting | 0.70378307 |
144 | MP0004130_abnormal_muscle_cell | 0.67073321 |
145 | MP0002332_abnormal_exercise_endurance | 0.63520447 |
146 | MP0008874_decreased_physiological_sensi | 0.60694964 |
147 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59630538 |
148 | MP0005319_abnormal_enzyme/_coenzyme | 0.59602277 |
149 | MP0005083_abnormal_biliary_tract | 0.59057776 |
150 | MP0002006_tumorigenesis | 0.58408561 |
151 | * MP0009765_abnormal_xenobiotic_induced | 0.57872866 |
152 | MP0003795_abnormal_bone_structure | 0.56136202 |
153 | MP0003252_abnormal_bile_duct | 0.55693830 |
154 | MP0003656_abnormal_erythrocyte_physiolo | 0.55689848 |
155 | MP0000604_amyloidosis | 0.53731439 |
156 | MP0004484_altered_response_of | 0.53324559 |
157 | MP0000470_abnormal_stomach_morphology | 0.52383957 |
158 | MP0001853_heart_inflammation | 0.51416452 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 5.71733891 |
2 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.54513026 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.21843823 |
4 | Hypochromic microcytic anemia (HP:0004840) | 4.69493896 |
5 | Gastrointestinal infarctions (HP:0005244) | 4.66239157 |
6 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.50166322 |
7 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.48270644 |
8 | Keratoconjunctivitis sicca (HP:0001097) | 4.43741048 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 4.43150597 |
10 | Recurrent fungal infections (HP:0002841) | 4.35916190 |
11 | Hypoglycemic coma (HP:0001325) | 4.32226021 |
12 | Keratoconjunctivitis (HP:0001096) | 4.22914848 |
13 | Symptomatic seizures (HP:0011145) | 4.15346986 |
14 | Hypoglycemic seizures (HP:0002173) | 4.15170595 |
15 | Encephalitis (HP:0002383) | 4.14854104 |
16 | Hypochromic anemia (HP:0001931) | 3.93906347 |
17 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.88689596 |
18 | Vasculitis (HP:0002633) | 3.80254375 |
19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.69734688 |
20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.69734688 |
21 | Urticaria (HP:0001025) | 3.64160691 |
22 | Gingivitis (HP:0000230) | 3.59903730 |
23 | Type I transferrin isoform profile (HP:0003642) | 3.52014724 |
24 | Increased IgE level (HP:0003212) | 3.47933118 |
25 | Spontaneous hematomas (HP:0007420) | 3.46793133 |
26 | Hemoptysis (HP:0002105) | 3.32660665 |
27 | Generalized aminoaciduria (HP:0002909) | 3.32490289 |
28 | Chest pain (HP:0100749) | 3.26601854 |
29 | Peritonitis (HP:0002586) | 3.19896380 |
30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.18558906 |
31 | Anorexia (HP:0002039) | 3.17316043 |
32 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.16258703 |
33 | Large for gestational age (HP:0001520) | 3.15488767 |
34 | Dysostosis multiplex (HP:0000943) | 3.14955781 |
35 | Leukocytosis (HP:0001974) | 3.11003274 |
36 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.05269594 |
37 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.03927359 |
38 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.03927359 |
39 | Abnormal protein glycosylation (HP:0012346) | 3.03781011 |
40 | Abnormal glycosylation (HP:0012345) | 3.03781011 |
41 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.03781011 |
42 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.03781011 |
43 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.02594879 |
44 | Arterial thrombosis (HP:0004420) | 2.99119751 |
45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.98516686 |
46 | Abnormality of T cell number (HP:0011839) | 2.98214061 |
47 | Vacuolated lymphocytes (HP:0001922) | 2.94270866 |
48 | Prolonged bleeding time (HP:0003010) | 2.93869079 |
49 | T lymphocytopenia (HP:0005403) | 2.92273255 |
50 | Cellulitis (HP:0100658) | 2.89402961 |
51 | Pulmonary embolism (HP:0002204) | 2.86252125 |
52 | Abnormality of T cell physiology (HP:0011840) | 2.85460751 |
53 | Progressive neurologic deterioration (HP:0002344) | 2.79204472 |
54 | Increased IgM level (HP:0003496) | 2.78446627 |
55 | Chronic otitis media (HP:0000389) | 2.71444042 |
56 | Microcytic anemia (HP:0001935) | 2.70085645 |
57 | Abnormality of the pleura (HP:0002103) | 2.68846193 |
58 | Gingival bleeding (HP:0000225) | 2.68338657 |
59 | Hepatic necrosis (HP:0002605) | 2.66684942 |
60 | Cortical visual impairment (HP:0100704) | 2.64411284 |
61 | Gangrene (HP:0100758) | 2.63107383 |
62 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57571762 |
63 | Recurrent abscess formation (HP:0002722) | 2.48882224 |
64 | Granulocytopenia (HP:0001913) | 2.47623954 |
65 | Inflammation of the large intestine (HP:0002037) | 2.47444854 |
66 | Meningitis (HP:0001287) | 2.47432904 |
67 | IgM deficiency (HP:0002850) | 2.47380039 |
68 | Pustule (HP:0200039) | 2.47061681 |
69 | Papilledema (HP:0001085) | 2.44166037 |
70 | Hypothermia (HP:0002045) | 2.42992591 |
71 | Osteomyelitis (HP:0002754) | 2.42970481 |
72 | Sepsis (HP:0100806) | 2.41994678 |
73 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.40987038 |
74 | Hyperglycemia (HP:0003074) | 2.40175359 |
75 | Keratitis (HP:0000491) | 2.38198231 |
76 | Lymphopenia (HP:0001888) | 2.37318097 |
77 | Increased cerebral lipofuscin (HP:0011813) | 2.37309732 |
78 | Obstructive lung disease (HP:0006536) | 2.36776297 |
79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36776297 |
80 | Gastrointestinal inflammation (HP:0004386) | 2.36069887 |
81 | Mucopolysacchariduria (HP:0008155) | 2.35999608 |
82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35999608 |
83 | Amyloidosis (HP:0011034) | 2.35710594 |
84 | Petechiae (HP:0000967) | 2.34473886 |
85 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.30831241 |
86 | Epistaxis (HP:0000421) | 2.30011505 |
87 | Abnormality of the peritoneum (HP:0002585) | 2.29964925 |
88 | Abnormality of the endocardium (HP:0004306) | 2.29934782 |
89 | Recurrent bronchitis (HP:0002837) | 2.28818994 |
90 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28109314 |
91 | Abnormality of the pericardium (HP:0001697) | 2.28010285 |
92 | Eosinophilia (HP:0001880) | 2.27418318 |
93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26047181 |
94 | Reduced antithrombin III activity (HP:0001976) | 2.25503976 |
95 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.23220432 |
96 | Hypoplasia of the fovea (HP:0007750) | 2.23220432 |
97 | Myositis (HP:0100614) | 2.21466894 |
98 | Retinal dysplasia (HP:0007973) | 2.16706387 |
99 | Hepatosplenomegaly (HP:0001433) | 2.16365685 |
100 | Hypergammaglobulinemia (HP:0010702) | 2.15968138 |
101 | Acute necrotizing encephalopathy (HP:0006965) | 2.14899716 |
102 | Panhypogammaglobulinemia (HP:0003139) | 2.14746980 |
103 | Parakeratosis (HP:0001036) | 2.14322604 |
104 | Recurrent bacterial skin infections (HP:0005406) | 2.11809127 |
105 | Decreased circulating renin level (HP:0003351) | 2.11795236 |
106 | Vertigo (HP:0002321) | 2.11637333 |
107 | Acute hepatic failure (HP:0006554) | 2.09460650 |
108 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08288770 |
109 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08288770 |
110 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.08135202 |
111 | Acne (HP:0001061) | 2.07504459 |
112 | Glomerulopathy (HP:0100820) | 2.07366188 |
113 | Stomach cancer (HP:0012126) | 2.07201859 |
114 | Retrobulbar optic neuritis (HP:0100654) | 2.06519389 |
115 | Optic neuritis (HP:0100653) | 2.06519389 |
116 | Premature graying of hair (HP:0002216) | 2.06448439 |
117 | Episodic fever (HP:0001954) | 2.06252544 |
118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05726339 |
119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05726339 |
120 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05726339 |
121 | Type II lissencephaly (HP:0007260) | 2.03150422 |
122 | Abnormality of eosinophils (HP:0001879) | 2.02113746 |
123 | Cheilitis (HP:0100825) | 2.01149030 |
124 | Menstrual irregularities (HP:0000858) | 2.00770078 |
125 | Hepatocellular necrosis (HP:0001404) | 2.00648462 |
126 | Recurrent pneumonia (HP:0006532) | 1.99849609 |
127 | Neurofibrillary tangles (HP:0002185) | 1.99845405 |
128 | Abnormal pancreas size (HP:0012094) | 1.99498462 |
129 | Abnormality of T cells (HP:0002843) | 1.99101957 |
130 | Toxemia of pregnancy (HP:0100603) | 1.98367831 |
131 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.98282961 |
132 | Premature loss of primary teeth (HP:0006323) | 1.97428087 |
133 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96389863 |
134 | Orchitis (HP:0100796) | 1.94532507 |
135 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94011666 |
136 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93225477 |
137 | Duplicated collecting system (HP:0000081) | 1.92963138 |
138 | Skin ulcer (HP:0200042) | 1.92915166 |
139 | Patchy hypopigmentation of hair (HP:0011365) | 1.92368163 |
140 | Abnormality of the fovea (HP:0000493) | 1.92277910 |
141 | Recurrent sinusitis (HP:0011108) | 1.91810412 |
142 | Abnormality of macrophages (HP:0004311) | 1.91226834 |
143 | Abnormality of the intrinsic pathway (HP:0010989) | 1.90602736 |
144 | Hyperparathyroidism (HP:0000843) | 1.89552163 |
145 | Ketoacidosis (HP:0001993) | 1.89548934 |
146 | Polyneuropathy (HP:0001271) | 1.89543818 |
147 | Eczematoid dermatitis (HP:0000976) | 1.89522901 |
148 | Acute encephalopathy (HP:0006846) | 1.88647717 |
149 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86865171 |
150 | White forelock (HP:0002211) | 1.86060203 |
151 | Abnormality of the renal collecting system (HP:0004742) | 1.85574974 |
152 | Recurrent viral infections (HP:0004429) | 1.85352175 |
153 | Rough bone trabeculation (HP:0100670) | 1.85294469 |
154 | Abnormality of urine glucose concentration (HP:0011016) | 1.84945804 |
155 | Glycosuria (HP:0003076) | 1.84945804 |
156 | Retinal atrophy (HP:0001105) | 1.84566105 |
157 | Recurrent skin infections (HP:0001581) | 1.84494044 |
158 | Villous atrophy (HP:0011473) | 1.84386501 |
159 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.84386501 |
160 | Abnormality of iron homeostasis (HP:0011031) | 1.82663311 |
161 | Agammaglobulinemia (HP:0004432) | 1.82508760 |
162 | Anteriorly placed anus (HP:0001545) | 1.81976860 |
163 | Thrombocytosis (HP:0001894) | 1.81809793 |
164 | Insulin resistance (HP:0000855) | 1.81316450 |
165 | Slow saccadic eye movements (HP:0000514) | 1.80271192 |
166 | Pulmonary infiltrates (HP:0002113) | 1.79971345 |
167 | Gastrointestinal stroma tumor (HP:0100723) | 1.79709704 |
168 | Thyroid-stimulating hormone excess (HP:0002925) | 1.79162537 |
169 | Neutropenia (HP:0001875) | 1.78982662 |
170 | Skin rash (HP:0000988) | 1.78473518 |
171 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.77832837 |
172 | Hypermelanotic macule (HP:0001034) | 1.77616462 |
173 | Alveolar cell carcinoma (HP:0006519) | 1.76956629 |
174 | Autoimmune hemolytic anemia (HP:0001890) | 1.73333601 |
175 | Recurrent lower respiratory tract infections (HP:0002783) | 1.72971440 |
176 | Nasal polyposis (HP:0100582) | 1.70444311 |
177 | Chronic sinusitis (HP:0011109) | 1.69855037 |
178 | Increased serum ferritin (HP:0003281) | 1.69412471 |
Rank | Gene Set | Z-score |
---|---|---|
1 | INSRR | 4.51184776 |
2 | MAPK15 | 4.31163347 |
3 | STK16 | 3.29330065 |
4 | MAP2K3 | 2.99565912 |
5 | TYK2 | 2.90140704 |
6 | IRAK4 | 2.83554657 |
7 | PASK | 2.82856810 |
8 | TNK2 | 2.67578568 |
9 | TAOK3 | 2.62656835 |
10 | GRK6 | 2.36638447 |
11 | ERN1 | 2.31096637 |
12 | HIPK2 | 2.28450273 |
13 | EPHB1 | 2.26865827 |
14 | TXK | 2.22947948 |
15 | TEC | 2.21965450 |
16 | BLK | 2.16886174 |
17 | MAPKAPK5 | 2.10730229 |
18 | MAP4K1 | 2.09646877 |
19 | IRAK3 | 2.06004541 |
20 | TAOK1 | 1.98910370 |
21 | CDK19 | 1.95765627 |
22 | STK39 | 1.95058148 |
23 | EIF2AK3 | 1.78511506 |
24 | WNK4 | 1.78313915 |
25 | FGR | 1.74103922 |
26 | MAP3K11 | 1.70219101 |
27 | BTK | 1.68623287 |
28 | CLK1 | 1.63160798 |
29 | MAP3K3 | 1.62904387 |
30 | DYRK3 | 1.60626081 |
31 | FLT3 | 1.58119534 |
32 | TNIK | 1.57492756 |
33 | OXSR1 | 1.46483459 |
34 | UHMK1 | 1.45439052 |
35 | IRAK1 | 1.44526148 |
36 | BMPR1B | 1.31529026 |
37 | MUSK | 1.28162404 |
38 | SIK3 | 1.27465513 |
39 | YES1 | 1.24398665 |
40 | PIK3CG | 1.18664826 |
41 | KSR2 | 1.18631951 |
42 | MATK | 1.17100887 |
43 | ITK | 1.11565310 |
44 | CSK | 1.09545220 |
45 | MARK3 | 1.04939752 |
46 | IRAK2 | 1.00631334 |
47 | FES | 1.00148996 |
48 | VRK1 | 0.99740972 |
49 | PKN1 | 0.99585222 |
50 | PTK6 | 0.98491019 |
51 | MAP2K2 | 0.98461332 |
52 | FRK | 0.96409297 |
53 | SIK2 | 0.94634092 |
54 | BRSK2 | 0.91426900 |
55 | PRPF4B | 0.89805105 |
56 | PTK2B | 0.89586527 |
57 | MAP2K4 | 0.89577054 |
58 | TRPM7 | 0.89487781 |
59 | NTRK1 | 0.88964048 |
60 | MAP3K6 | 0.88156039 |
61 | JAK3 | 0.84494641 |
62 | KIT | 0.83480348 |
63 | CAMKK2 | 0.81534086 |
64 | GRK1 | 0.80764097 |
65 | SYK | 0.80736053 |
66 | LCK | 0.80685394 |
67 | CASK | 0.80063968 |
68 | PDK1 | 0.79655014 |
69 | STK11 | 0.79405228 |
70 | DAPK2 | 0.78433561 |
71 | RPS6KA5 | 0.77975319 |
72 | NEK6 | 0.76130371 |
73 | WNK3 | 0.75952554 |
74 | MAP2K6 | 0.73770468 |
75 | ZAP70 | 0.72291824 |
76 | MET | 0.72092597 |
77 | CAMK2D | 0.71474534 |
78 | BMPR2 | 0.71403373 |
79 | TLK1 | 0.70633723 |
80 | MAP3K14 | 0.70137348 |
81 | LYN | 0.69717133 |
82 | SCYL2 | 0.69155425 |
83 | MAP3K7 | 0.68690614 |
84 | CAMK2B | 0.68179803 |
85 | NLK | 0.67546719 |
86 | DMPK | 0.67494670 |
87 | STK10 | 0.66836110 |
88 | JAK1 | 0.66491457 |
89 | FYN | 0.65014103 |
90 | PDPK1 | 0.62970110 |
91 | DYRK2 | 0.61696816 |
92 | MAPKAPK2 | 0.61601269 |
93 | MAP3K5 | 0.60033618 |
94 | FGFR3 | 0.59418218 |
95 | MKNK1 | 0.59085385 |
96 | MAP3K1 | 0.57046474 |
97 | TAOK2 | 0.56368664 |
98 | CSNK1G3 | 0.53604734 |
99 | MST4 | 0.52556934 |
100 | GSK3A | 0.52069743 |
101 | PRKCZ | 0.51556802 |
102 | LRRK2 | 0.51367723 |
103 | PRKG1 | 0.51319220 |
104 | CDC42BPA | 0.51233439 |
105 | PRKCQ | 0.50814061 |
106 | STK38 | 0.50031151 |
107 | ACVR1B | 0.49221626 |
108 | RIPK4 | 0.48614216 |
109 | EPHA3 | 0.48441352 |
110 | WNK1 | 0.47599427 |
111 | DYRK1B | 0.47482332 |
112 | FGFR4 | 0.47115219 |
113 | GRK7 | 0.46767777 |
114 | MAP3K13 | 0.46147280 |
115 | TGFBR2 | 0.45832723 |
116 | PRKCH | 0.45823538 |
117 | CSNK1G1 | 0.45300916 |
118 | CSNK1A1L | 0.45154791 |
119 | BCKDK | 0.45144845 |
120 | SGK3 | 0.45041647 |
121 | CDK3 | 0.44438732 |
122 | PRKD2 | 0.43742728 |
123 | RAF1 | 0.43406127 |
124 | MAPK7 | 0.42963905 |
125 | IKBKB | 0.41984175 |
126 | KSR1 | 0.41817007 |
127 | PIM1 | 0.41370895 |
128 | MAPK12 | 0.40792733 |
129 | SGK2 | 0.40576703 |
130 | PRKCE | 0.40308357 |
131 | RET | 0.39209352 |
132 | ADRBK2 | 0.38523371 |
133 | MARK2 | 0.38320092 |
134 | PRKG2 | 0.38202716 |
135 | ADRBK1 | 0.38013256 |
136 | RPS6KA6 | 0.35985235 |
137 | CSF1R | 0.35915215 |
138 | PRKCD | 0.33612743 |
139 | TESK2 | 0.33274854 |
140 | IKBKE | 0.32931239 |
141 | CDK9 | 0.32581053 |
142 | RPS6KA2 | 0.31998965 |
143 | BCR | 0.31875764 |
144 | PRKD1 | 0.31748548 |
145 | PIM2 | 0.31692711 |
146 | MKNK2 | 0.31597019 |
147 | PRKAA2 | 0.30689113 |
148 | JAK2 | 0.30488516 |
149 | HCK | 0.30013745 |
150 | TBK1 | 0.29641863 |
151 | BRD4 | 0.27963380 |
152 | MAP3K2 | 0.27852596 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 7.26184772 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.36568741 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.03689897 |
4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.62026945 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.55860429 |
6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.54185130 |
7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.51993152 |
8 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.28911211 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.26419748 |
10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.23440629 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12093212 |
12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.08260803 |
13 | Measles_Homo sapiens_hsa05162 | 2.02697094 |
14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82581579 |
15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71598600 |
16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67864351 |
17 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.63953325 |
18 | Influenza A_Homo sapiens_hsa05164 | 1.61459134 |
19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.59657014 |
20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.57097366 |
21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.54443702 |
22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54139232 |
23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47731337 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45524919 |
25 | Lysosome_Homo sapiens_hsa04142 | 1.43921481 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43431441 |
27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40970417 |
28 | Asthma_Homo sapiens_hsa05310 | 1.39953653 |
29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34643014 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33694879 |
31 | ABC transporters_Homo sapiens_hsa02010 | 1.28407458 |
32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25495606 |
33 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22674302 |
34 | Hepatitis C_Homo sapiens_hsa05160 | 1.22288747 |
35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.19022626 |
36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17559057 |
37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17007622 |
38 | Insulin secretion_Homo sapiens_hsa04911 | 1.15813753 |
39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13795514 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12099754 |
41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11510313 |
42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09965919 |
43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09863061 |
44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09018390 |
45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08546467 |
46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07530311 |
47 | Hepatitis B_Homo sapiens_hsa05161 | 1.06704618 |
48 | Homologous recombination_Homo sapiens_hsa03440 | 1.04769862 |
49 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04630446 |
50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03334788 |
51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02701635 |
52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02639763 |
53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02585263 |
54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98151588 |
55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97422652 |
56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93364790 |
57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92205506 |
58 | Ribosome_Homo sapiens_hsa03010 | 0.91424769 |
59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91258765 |
60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89986590 |
61 | Salmonella infection_Homo sapiens_hsa05132 | 0.89579308 |
62 | DNA replication_Homo sapiens_hsa03030 | 0.89055616 |
63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88420020 |
64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86979157 |
65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86408664 |
66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85421940 |
67 | Mismatch repair_Homo sapiens_hsa03430 | 0.85381517 |
68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83634346 |
69 | Shigellosis_Homo sapiens_hsa05131 | 0.83198643 |
70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82757311 |
71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81022974 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80493168 |
73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.78902097 |
74 | Apoptosis_Homo sapiens_hsa04210 | 0.78869770 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77935258 |
76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74049079 |
77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71195591 |
78 | Endocytosis_Homo sapiens_hsa04144 | 0.70194060 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69801093 |
80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68607476 |
81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68385821 |
82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67141651 |
83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66961796 |
84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65687198 |
85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65588210 |
86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65451898 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64778119 |
88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61843893 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61250474 |
90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60579907 |
91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59521257 |
92 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59406577 |
93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58395720 |
94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58200722 |
95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57508939 |
96 | Allograft rejection_Homo sapiens_hsa05330 | 0.57386352 |
97 | Pertussis_Homo sapiens_hsa05133 | 0.55336542 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55074366 |
99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54619676 |
100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54522301 |
101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53333900 |
102 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53242031 |
103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53117405 |
104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51598245 |
105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50858690 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49300454 |
107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47857757 |
108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46875047 |
109 | Insulin resistance_Homo sapiens_hsa04931 | 0.46803885 |
110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46430515 |
111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46196889 |
112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45768059 |
113 | Peroxisome_Homo sapiens_hsa04146 | 0.44868132 |
114 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.44542795 |
115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44508403 |
116 | Phagosome_Homo sapiens_hsa04145 | 0.44165847 |
117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43536649 |
118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42333763 |
119 | Amoebiasis_Homo sapiens_hsa05146 | 0.39821967 |
120 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39437899 |
121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39222833 |
122 | RNA polymerase_Homo sapiens_hsa03020 | 0.39170908 |
123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39102143 |
124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38731249 |
125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38580838 |
126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38177766 |
127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37943738 |
128 | Base excision repair_Homo sapiens_hsa03410 | 0.37092355 |
129 | Taste transduction_Homo sapiens_hsa04742 | 0.36599506 |
130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35894644 |
131 | Legionellosis_Homo sapiens_hsa05134 | 0.35326478 |
132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35193148 |
133 | Alcoholism_Homo sapiens_hsa05034 | 0.33204839 |
134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32732444 |
135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32369365 |
136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32311157 |
137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31821900 |
138 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31298644 |
139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30430531 |
140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30153341 |
141 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29997899 |
142 | RNA degradation_Homo sapiens_hsa03018 | 0.29854634 |
143 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.29773635 |
144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29161850 |
145 | Platelet activation_Homo sapiens_hsa04611 | 0.28944913 |
146 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.27538584 |
147 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26834871 |
148 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26801263 |
149 | Basal transcription factors_Homo sapiens_hsa03022 | 0.26682033 |
150 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26033767 |
151 | Colorectal cancer_Homo sapiens_hsa05210 | 0.24825321 |
152 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24187536 |
153 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24078340 |
154 | Malaria_Homo sapiens_hsa05144 | 0.23290489 |
155 | Purine metabolism_Homo sapiens_hsa00230 | 0.21996136 |
156 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.21788559 |